Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

Adenuric (febuxostat) - Important Safety Information from Menarini as approved by the Irish Medicines Board

21 May 2012

Important Safety Information communication from Menarini on the association of the risk of serious hypersensitivity reactions, including Stevens-Johnson Syndrome and acute anaphylactic reaction/shock, with Adenuric (febuxostat).

Important Safety Information - Adenuric (febuxostat)





Date Printed: 21 May 2013

© Irish Medicines Board 2013 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971